TY - JOUR T1 - Prolonged presence of replication-competent SARS-CoV-2 in mildly symptomatic individuals: A Report of 2 Cases JF - medRxiv DO - 10.1101/2020.11.18.20232546 SP - 2020.11.18.20232546 AU - Maria Cassia Mendes-Correa AU - Fabio E. Leal AU - Lucy S. Villas-Boas AU - Steven S. Witkin AU - Anderson de Paula AU - Tania Regina Tozetto-Mendonza AU - Noely Evangelista Ferreira AU - Gislaine Curty AU - Pedro Santos de Carvalho AU - Lewis F. Buss AU - Silvia F. Costa AU - Flavia Mendes da Cunha Carvalho AU - Joyce Kawakami AU - Noemi Nosomi Taniwaki AU - Heuder Paiao AU - Joao Carlos da Silva Bizário AU - Jaqueline Goes de Jesus AU - Ester Cerdeira Sabino AU - Camila Malta Romano AU - Regina Maura Zetone Grepan AU - Antonio Sesso Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/11/20/2020.11.18.20232546.abstract N2 - It has been estimated that individuals with COVID-19 can shed replication-competent virus up to a maximum of twenty days after initiation of symptoms. This report describes two patients with mild forms of the disease who shed replication-competent virus for 24 and 37 days, respectively, after symptom onset.Competing Interest StatementThe authors have declared no competing interest.Funding StatementAuthors involved in the manuscript or study design did not receive any kind oy payment for their service. The study was funded by Virology Laboratory from Instituto de Medicina Tropical-Faculdade de Medicina da Universidade de Sao Paulo.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the local ethics committee (Comissao de Etica para Analise de Projeto de Pesquisa - CAPPesq, protocol No. 13915, dated June 03, 2020).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data referred to in the manuscript is avaiable for consultation at any time. ER -